SavvY logo
flag US
Biochimpharm.png

Biochimpharm Financial Model

BCP.jpg

Biochimpharm

Biochemistry is a phage-producing company which is aimed at maximizing the long-term experience of phagicides in order to simplify the fight against bacterial infections.

SavvY created a financial model for a new production unit of Biochimpharm and evaluated the existing project: its investment volume, assumptions, profitability, cost, and revenue structure. Using a 5-year financial model, the company’s project was assessed reliably for investors.

Services

Financial Modeling

Date

2017

Project Url

View website